NSBBs , EBL or Combined Therapy for High‐Risk Varices: Systematic Review and Meta‐Analysis
Liver International · 2025
DOI: 10.1111/liv.70145 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Liver International, 2025. Verfasst von Sreeram Pannala und 9 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Staten Island University Hospital, Staten Island, New York, USA. Hauptthemen laut MEDLINE: Esophageal and Gastric Varices, Adrenergic beta-Antagonists, Gastrointestinal Hemorrhage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background and Aims Non‐selective beta blocker (NSBB) is the preferred treatment option for primary prophylaxis of high‐risk oesophageal varices, and endoscopic band ligation (EBL) is reserved for those intolerant to NSBB. In this meta‐analysis, we aim to compare the outcomes of NSBB, EBL and combined therapy for primary prophylaxis of high‐risk oesophageal varices.
Methods
Major databases, such as MedLine, Embase and Cochrane Library were searched in October 2024 to identify studies comparing clinical outcomes between combined approaches versus NSBB versus EBL only. Only randomised trials were included. Meta‐analysis was performed using the random‐effects model, and heterogeneity was assessed by I 2 % statistics.
Results
Six randomised trials were included, which consisted of 1011 participants (NSBB 302, EBL 300 and 409 combined) (75.27% males), with an average age of 51.06 years. The NSBBs used were propranolol, nadolol and carvedilol, with an average follow‐up of 17.54 months. The combined approach significantly reduced the first episode of variceal bleeding compared to NSBB alone (pooled RR 0.39 [95% CI 0.19–0.76], p = 0.009) and EBL alone (RR 0.46, 0.29–0.74; p = 0.002). The pooled rate of bleeding with the combined approach was 9.4% [95% CI 6%–14.3%], with NSBB being 28.2% [95% CI 12.9%–51%] and with EBL being 13.9% [6%–17%]. Pooled ratios for bleeding‐related mortality were significantly better with the combined approach when compared to NSBB alone.
Conclusion
Primary prophylaxis of high‐grade varices by combined therapy demonstrated a significantly lower risk of variceal bleeding than NSBB or EBL alone. We recommend these findings be incorporated into forthcoming guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Internal Medicine, Staten Island University Hospital, Staten Island, New York, USA.
- Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
- Gastroenterology & Hepatology, Singapore General Hospital, Singapore.
- Internal Medicine, University of Texas Health Science Center San Antonio (UTHSCSA), San Antonio, Texas, USA.
- College of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York, USA.
- Gastroenterology & Hepatology, Virginia Tech Carilion School of Medicine (VTCSOM), Roanoke, Virginia, USA.
ORCID-Profile: Sreeram Pannala, Daniel Yan Zheng Lim, Arvind Murali
Zitieren
APA
Pannala, S., Byale, A., Bin, T. Y., Loganathan, P., Baskar, V., Mir, A., Lim, D. Y. Z., Asokkumar, R., Murali, A., & Mohan, B. P. (2025). NSBBs , EBL or Combined Therapy for High‐Risk Varices: Systematic Review and Meta‐Analysis. Liver International. https://doi.org/10.1111/liv.70145
Vancouver
Pannala S, Byale A, Bin TY, Loganathan P, Baskar V, Mir A, et al. NSBBs , EBL or Combined Therapy for High‐Risk Varices: Systematic Review and Meta‐Analysis. Liver International. 2025. doi:10.1111/liv.70145
BibTeX
@article{Pannala2025,
author = {Pannala, Sreeram and Byale, Anjali and Bin, Tan Yu and Loganathan, Priyadarshini and Baskar, Viknesh and Mir, Adil and Lim, Daniel Yan Zheng and Asokkumar, Ravishankar and Murali, Arvind and Mohan, Babu P},
title = {NSBBs , EBL or Combined Therapy for High‐Risk Varices: Systematic Review and Meta‐Analysis},
journal = {Liver International},
year = {2025},
doi = {10.1111/liv.70145}
}
EUVIMED